Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Acrux Limited ( (AU:ACR) ) has issued an update.
Acrux Limited has announced the issuance of free attaching options to acquire fully paid ordinary shares under a new prospectus, effective January 17, 2025. These options are being offered to eligible shareholders, investors, and lead managers, with conditions including shareholder approval and an exercise price set at $0.0525. This initiative aims to strengthen Acrux’s market position by leveraging strategic investments and partnerships.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical sector, focusing on developing and commercializing products in the healthcare market.
YTD Price Performance: 10.0%
Average Trading Volume: 3,250
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.01M
See more data about ACR stock on TipRanks’ Stock Analysis page.
